TrialLeukemia2011

Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.

H J M de Jonge et al.PubMed ↗Publisher ↗

No numbers read from the abstract.